Comparative Kinetic Analysis of OXA-438 with Related OXA-48-Type Carbapenem-Hydrolyzing Class D β-Lactamases

Denise De Belder1,2, Barbara Ghiglione2,3, Fernando Pasteran1

  • 1Servicio Antimicrobianos - National Reference Laboratory in Antimicrobial Resistance (NRLAR), Instituto Nacional de Enfermedades Infecciosas-ANLIS "Dr. Carlos G. Malbrán", Buenos Aires 1282, Argentina.

ACS Infectious Diseases
|September 24, 2020
PubMed

Insights

Novel OXA-48-like carbapenemase variants, OXA-163, OXA-247, and OXA-438, are spreading in Argentina. These enzymes show varying resistance to carbapenems and cephalosporins due to mutations, impacting treatment options.

Area of Science:

  • Molecular biology
  • Microbiology
  • Biochemistry

Background:

  • OXA-48-type enzymes are a growing concern due to their ability to hydrolyze carbapenems and oxyimino-cephalosporins.
  • OXA-163, first reported in 2011, is widespread in Argentina, with variants like OXA-247 also emerging.
  • Understanding the enzymatic properties and genetic basis of these variants is crucial for combating antimicrobial resistance.

Purpose of the Study:

  • To characterize a new OXA-48-like variant, OXA-438.
  • To perform a comparative kinetic analysis of OXA-438 against local variants (OXA-163, OXA-247) and the globally prevalent OXA-48.
  • To investigate the impact of specific mutations on enzyme activity and resistance profiles.

Main Methods:

  • Genetic characterization of blaOXA-48-like variants.
  • Kinetic analysis (kcat/Km) of enzyme activity against various beta-lactam antibiotics.
  • Determination of minimum inhibitory concentrations (MICs) in transconjugant strains.
  • Circular dichroism to assess structural stability.

Main Results:

  • OXA-163, OXA-247, and OXA-438 were located on a 70 kb IncN2 conjugative plasmid.
  • OXA-438 possesses mutations near the conserved KTG motif, including a 2-amino acid deletion and a D224E substitution.
  • Transconjugants expressing OXA-163 and OXA-48 showed resistance to oxyimino-cephalosporins, while OXA-247 and OXA-438 transconjugants did not.
  • All three variants conferred resistance to meropenem and ertapenem, with OXA-163, OXA-247, and OXA-438 exhibiting higher carbapenem MICs than the acceptor strain.
  • Mutations in OXA-247 and OXA-438 likely enhance carbapenem hydrolysis and reduce oxyimino-cephalosporin inactivation compared to OXA-163.
  • Deletions in the β5-β6 loop appear to affect the structural stability of OXA-48 variants.

Conclusions:

  • OXA-438 represents a new OXA-48-like variant with distinct kinetic properties and resistance profiles.
  • Mutations near the KTG motif significantly influence the hydrolytic activity against different beta-lactams.
  • Additional resistance mechanisms may be involved in the observed resistance patterns in clinical isolates.